v3.26.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
6 Months Ended
Jun. 27, 2026
Jun. 28, 2025
Operating Activities:    
Net income $ 946,999 $ 733,591
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation 81,270 75,980
Amortization 16,711 17,423
Loss on sale or disposal of property and equipment 55 350
Unrealized foreign currency losses (gains) 2,575 (16,566)
Deferred income taxes 3,418 (49,754)
Stock compensation expense 88,793 82,279
Realized loss on marketable securities 597 706
Changes in operating assets and liabilities, net of acquisitions:    
Accounts receivable, net of allowance for doubtful accounts 84,187 17,902
Inventories (209,361) (206,276)
Other current and non-current assets (44,687) (37,092)
Accounts payable 59,547 (2,591)
Other current and non-current liabilities (68,307) 2,408
Deferred revenue 1,187 (6,843)
Deferred costs 4,310 7,262
Income Taxes (27,750) (24,820)
Net cash provided by operating activities 939,544 593,959
Investing activities:    
Purchases of property and equipment (194,395) (85,738)
Purchase of marketable securities (510,525) (465,372)
Redemption of marketable securities 311,308 306,469
Net payments for acquisitions (2,993) (1,973)
Other investing activities, net (68) 503
Net cash used in investing activities (396,673) (246,111)
Financing activities:    
Dividends (376,045) (317,748)
Proceeds from issuance of treasury shares related to equity awards 31,442 29,065
Purchase of treasury shares related to equity awards (47,063) (33,431)
Purchase of treasury shares under share repurchase plan (81,581) (93,632)
Net cash used in financing activities (473,247) (415,746)
Effect of exchange rate changes on cash and cash equivalents (14,014) 60,650
Net increase (decrease) in cash, cash equivalents, and restricted cash 55,610 (7,248)
Cash, cash equivalents, and restricted cash at beginning of period 2,279,360 2,080,154
Cash, cash equivalents, and restricted cash at end of period $ 2,334,970 $ 2,072,906